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To generate BJNhem20-TetR cell line, we transfected BJNhem20 by microporation at 1100 V, 30 ms pulse width and 1 pulse number. A stable hESC line was generated after subjecting these transfected cells to puromycin selection for two weeks. Expression of pluripotent stem cell markers OCT4, SSEA3, TRA1-60 and TRA1-81 has been shown by immunostaining. Differentiation of BJNhem20-TetR to all the three germ layers was demonstrated by immunostaining for beta III tubulin (ectodermal), Brachyury (mesodermal) and AFP (endodermal). Karyotype was also checked in these cells and found to be normal.
Materials and methods

Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos and tested for pluripotency (Inamdar et al., 2009 ). This cell line has been cultured continuously for over 200 passages without acquiring any karyotypic abnormality (Venu et al., 2010 without ROCK inhibitor was used after 12-16 h when the cells adhered. 48 h after transfection, puromycin (0.5 μg/ml Sigma Aldrich Pvt. Ltd.; Cat no. P8833) was added to the transfected culture and selection was continued for 10 days. Puromycin resistant individual clones were manually picked and passaged. BJNhem20-TetR cells were subsequently cultured in both feeder free conditions on matrigel in the presence of mTESR medium and on feeders with regular hESC medium.
Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described before (Inamdar et al., 2009) . Briefly, colonies grown on MEFs were mechanically cut and pieces cultured in human embryoid body media (10% FBS-Hyclone; Cat no. SH30070 with β-mercaptoethanol and GlutaMAX in DMEM) on low attachment plates. These hESC aggregates were allowed to grow in suspension for 3 days after which the colonies formed embryoid body-like structures and were transferred to the tissue culture dishes pre-treated with 0.1% gelatin and allowed to attach and differentiate spontaneously till the time for harvest from day 6 onwards for immunostaining analyses.
Immunostaining hESC and hEBs were fixed in 2% paraformaldehyde (in PBS), permeabilized with Triton-X 100 (0.1% for cells and 0.3% for EBs) and then blocked with 4% FBS for 1 h at RT (Room Temperature). Post blocking, cells were incubated with the appropriate primary antibodies overnight at 4°C, then were washed with PBS at RT and incubated with secondary antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT (Dilution 1:400 Invitrogen). The cells were washed and stained using DAPI (1:500 in M1 buffer Invitrogen) to visualize nuclei. The images were acquired using an epifluorescence microscope (IX-81 microscope system (Olympus)) fitted with a cooled CCD camera (CoolSnap, Roper Scientific). Primary antibodies used were against TetR (Clonetech; Clone 9G9 Cat no. 631131), Oct4 (BD Biosciences BD611203), TRA1-81 and SSEA3 monoclonal antibodies were a kind gift from Peter Andrews (University of Sheffield, UK), Brachyury (Santa Cruz Biotech; Cat no. SC-17743), β-III tubulin, AFP (Sigma Chemical Pvt. Ltd.; Cat no. A8452).
RNA isolation/cDNA synthesis and PCR
Total RNA was extracted from cells by TRIzol reagent (Life Technologies; Cat no. 15596-026) following the manufacturer's instructions. 2 μg of DNase treated RNA was converted to cDNA by performing reverse transcription using Superscript II (Life Technologies; Cat no. 18064-014). Primer sequences used for cDNA amplification (5′-3′) were as follows:
Primer name  Sequence   OCT4_F  GAAGGTATTCAGCCAAACGAC  OCT4_R  GTTACAGAACCACACTCGGA  SOX2_F  AGTCTCCAAGCGACGAAAAA  SOX2_R  GCAAGAAGCCTCTCCTTGAA  GAPDH_F  GTCCATGCCATCACTGCCA  GAPDH_R  TTACTCCTTGGAGCCATG  TET_F  GGTTGCGTATTGGAAGAT  TET_R TTCAAGGCCGAATAAGAA
Verification of karyotype
Standard G banding of metaphase spreads was performed and analysed using CytoVision software. For each sample, at least 50 metaphases were counted and 10 were analysed.
